Cultivating hope one star sperm at a time

Improved success in ART

Spermotile improves the success rates of assisted reproductive technologies such as IUI, IVF and ICSI by as much as 20%.

Reduced pain and cost

Spermotile reduces the number of cycles per patient by improving the success rate of fertilization. This reduces both the pain and the cost of the treatment.

Star sperm selection

Spermotile uses a patent-pending technology to identify the best sperms in terms of morphology, motility, kinematics and nanoscale motion patterns in a chemical-free manner.

Infertility

As infertility rates rise globally, affecting 15% of couples, the demand for ART (Assisted Reproduction Technologies) has increased. But ART is demanding — physically, psychologically, and financially — with no guarantee of success. Selecting the highest quality sperm for fertilization can improve ART outcomes.

News & Award

Featured in Forbes India Leadership Award print issue(7th Mar’25)

A-list certificate and interview at leading news channel NewsX

Spermotile Founders Selected for EIC Women Leadership Program

Spermotile bags Asia’s Leading Brands and Leaders Award 2024 by Film Actress Vaani kapoor

Spermotile selected for Best Innovation in Fertility Technology by Business Connect

Spermotile reaches 4 Million Euros mark of public funding

Spermotile awarded the prestigious RCN Verification funding

Femina Achievers Award for Innovation in Fertility Treatment from Ex- Minister of State for External Affairs, India Ms. Meenakshi Lekhi

Spermotile featured in NordLys

Spermotile celebrates international women day

Spermotile awarded EIC transition grant, under lean success rate of <10%

Spermotile: only Norwegian application funded by EIC Transition 2024 calls

Research outcome published in Fertility & Science journal

AI based Sperm detection published in ICPR Workshop 2024

Funding, Partners & Stakeholder

EIC Transition 2025

Norway – RCN Verification 2025

EU ERC-POC 2023

Norway – RCN Qualification 2024

Norway – RCN Qualification 2023

Norway – RCN Verification 2024

Innovation Norway(REACH Program)

University Hospital North Norway

UiT Innovation support

TTO-Norrinova

Improve ART success rate with Spermotile

Presenting Spermotile: a game-changer in ART, aimed at boosting fertilization rates and minimizing treatment cycles. Spermotile’s groundbreaking computer-assisted semen analysis (CASA) identifies the top-quality sperms, termed ‘star sperms,’ without using harmful stains, which are then filtered by Spemotile’s non-chemical and extremely gentle patent pending technology’.